Table 3.
Patient outcomes at baseline and the end of 3 months
| Normal ranges | Baseline n = 42 |
Third Month n = 42 |
p value | |
|---|---|---|---|---|
| Endotrophin | – | 15.35 ± 9.77 | 12.20 ± 6.49 | 0.010 |
| HbA1c (%) | ≤ 7 | 10.90 ± 1.71 | 6.64 ± 0.36 | < 0.001 |
| Fasting glucose (mg/dL) | < 104 | 258.97 ± 93.55 | 125.97 ± 14.63 | < 0.001 |
| CRP (mg/L) | 0–5 | 6.01 ± 4.24 | 4.60 ± 3.69 | 0.050 |
| BMI (kg/m2) | 18–25 | 29.37 ± 4.64 | 29.29 ± 4.41 | 0.412 |
| HDL, mg/dL | > 50 | 43.92 ± 8.96 | 44.14 ± 8.38 | 0.865 |
| LDL, mg/dL | < 130 | 144.14 ± 32.64 | 136 ± 69 ± 30.82 | 0.160 |
| TG, mg/dL | < 150 | 197.97 ± 100.22 | 180.66 ± 78.71 | 0.208 |
| UACR, mg/g | 0–30 | 15.35 ± 16.04 | 10.80 ± 9.75 | < 0.001 |
BMI body mass index, HbA1c hemoglobin A1c, CRP, C-reactive protein, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, TG triglyceride, UACR urinary albumin to creatinine(mg/g) ratio